TRexBio is a clinical-stage biotechnology company discovering and developing immunoregulatory medicines based on tissue-resident regulatory T cell (Treg) biology.
The company leverages computational biology and a proprietary Deep Biology Platform to map human tissue Treg behavior and advance tissue-targeted therapies for autoimmune and inflammatory diseases.
Leadership & Board
Current Number of Employees61
Current LinkedIn Followers13,131
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$50M
Total Amount Raised$50M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$50M
Latest Funding Amount$50M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
TRexBio Inc had 61 employees as of September 14, 2026. The number of employees increased by 0 (0.00%) week-over-week.
61Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
TRexBio Inc had 13,131 followers as of September 14, 2026. The number of followers increased by 23 (0.18%) week-over-week.
13,131Latest Followers Count
23(0.18%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.